Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.

Of note, the C>A/T dominant subgroup had a two-fold higher frequency of ERBB2 / MET co-amplifications, but this did not reach statistical significance.

also in 111,027 other papers